Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma.
It has been established that loss of tumour suppressor genes is crucial in carcinogenesis. There has been no reported study on searching for tumour suppressor genes in cholangiocarcinomas as yet. In order to investigate the loss of heterozygosity (LOH), which may represent such gene loss, in cholangiocarcinoma, we studied 14 patients with this tumour using restriction fragment length polymorphism analysis. Twenty-two probes assigned to chromosomes 1, 5, 7, 9, 11, 12, 13, 14, 16, 17 and 18 were used. Allelic losses were found in chromosomal regions 5q35-qter and 17p13. Loss of genetic material in these regions in cholangiocarcinoma was shared with hepatocellular carcinoma. Probes for other chromosomes have as yet shown no consistent LOH. In conclusion, this study for the first time showed LOH on chromosomes 5 and 17 in cholangiocarcinoma.
Department of Surgery, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
S F
SF
Ding
J D
JD
Delhanty
L
L
Bowles
J S
JS
Dooley
C B
CB
Wood
N A
NA
Habib
D002759:Adenoma, Bile Duct / Q000235:genetics*; D015139:Blotting, Southern; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002886:Chromosomes, Human, Pair 17; D002895:Chromosomes, Human, Pair 5; D006579:Heterozygote; D006801:Humans